Stock Market
The Tiger Zone: Power Metallic’s Promising New Polymetallic Discovery Backed By Billionaires
Power Metallic Mines Inc. [TSXV: PNPN OTC: PNPNF] has been making news once again in the mining exploration sector with its recent discoveries at the NISK project in Quebec. Among these discoveries, the “Tiger Zone” has emerged as an increasingly compelling prospect that has been featured prominently in the company’s recent press releases. This article explores what the Tiger Zone is, its significance, and why it’s generating excitement for Power Metallic and its investors.
Location and Context
The Tiger Zone is located approximately 700 meters northeast of the already established Lion Zone within Power Metallic’s flagship NISK project in Quebec, Canada. It represents one segment of an extensive exploration effort that spans approximately 8 kilometers of favorable stratigraphy. The NISK project itself is positioned in one of the safest and most supportive mining jurisdictions in the world, with excellent infrastructure including proximity to a major highway, nearby town and airport, and access to low-carbon hydropower from a Hydro-Québec substation across the road.
The Tiger Zone is part of a broader exploration campaign that includes multiple target areas: the Lion Zone, Nisk Zone, Nisk East Zone, and Tiger Zone. These zones collectively form what Power Metallic believes could become a polymetallic supergiant deposit, comparable to the famous Norilsk deposit, with high grades of copper, nickel, platinum, palladium, cobalt, gold, and silver.
Discovery History
The discovery of the Tiger Zone represents a textbook example of modern mineral exploration techniques. The story begins with the identification of a weak airborne electromagnetic (EM) anomaly approximately 700 meters northeast of the established Lion Zone.
In late 2024, Power Metallic drilled hole PN-24-090 to test this anomaly. While this initial hole appeared to miss the primary source of the airborne anomaly, it nevertheless returned multiple narrow zones containing copper, platinum group elements (PGEs), gold, silver, and traces of nickel. These results, while not spectacular, confirmed the presence of a mineralized structure and warranted further investigation.
The exploration team then employed a sophisticated technique called borehole electromagnetic surveying (BHEM) in hole PN-24-090. This survey identified an “off-hole conductor” – essentially a signal indicating the presence of conductive material (potentially sulfide mineralization) near but not intersected by the drill hole.
This off-hole conductor was subsequently targeted with hole PN-24-094, which successfully intersected narrow zones of massive nickel-copper sulfides. This hole is now recognized as the discovery hole for the Tiger Zone. The success of this methodology – using geophysical techniques to vector toward mineralization – demonstrates the technical expertise of Power Metallic’s exploration team.
Geological Characteristics
The Tiger Zone has distinct geological characteristics that make it an intriguing target for further exploration. Geologists at Power Metallic interpret the Tiger Zone to contain “mobilized sulfides” that originated from a proximal ultramafic source rock and were subsequently emplaced in the footwall paragneiss (a type of metamorphic rock).
What makes the Tiger Zone particularly interesting is its mineralization style. The zone exhibits what Power Metallic describes as “Lion style polymetallic mineralization,” which is copper-dominant but contains a suite of valuable metals including nickel, platinum, palladium, gold, silver, and cobalt. This polymetallic nature enhances the economic potential of the discovery.
A notable feature of the Tiger Zone is the shallow depth of mineralization, with intersections occurring just 40-60 meters below surface. This shallow depth could potentially translate to lower mining costs if the deposit proves economically viable for development.
Currently, Tiger remains the smallest mineralized zone along the Nisk trend, but according to Power Metallic, it “retains good potential for a significant polymetallic discovery.” The +300-meter distance along strike between drill holes provides a large untested area for additional exploration, suggesting that what has been discovered so far may be just the beginning.
Drilling Results
The drilling results from the Tiger Zone have evolved from initial narrow intersections to more substantial mineralized zones in recent drilling campaigns.
The initial discovery drilling in late 2024 (reported in the March 25, 2025 press release) yielded the following key results:
- Hole PN-24-090: Multiple narrow zones including 1.75m @ 1.01% CuEq (copper equivalent), 2.00m @ 0.84% CuEq, and 1.20m @ 0.78% CuEq
- Hole PN-24-094: 9.90m @ 1.77% CuEq including 2.50m @ 2.95% CuEq and 2.20m @ 4.50% CuEq
The follow-up winter 2025 drilling campaign (reported in the April 17, 2025 press release) tested off-hole EM anomalies generated from the previous drill holes and returned these significant results:
- Hole PN-25-098: 2.00m @ 0.77% CuEqRec and 1.20m @ 0.53% CuEqRec
- Hole PN-25-099: 2.00m @ 1.16% CuEqRec and 14.30m @ 0.96% CuEqRec including 6.00m @ 1.84% CuEqRec
- Hole PN-25-101: 2.00m @ 0.77% CuEqRec
- Hole PN-25-102: 1.00m @ 6.37% CuEqRec
These results reveal two particularly significant developments. First, hole PN-25-099 provided the first indication at Tiger of broader widths of a Lion style polymetallic zone (14.3 meters @ 0.96% CuEqRec). Second, while hole PN-25-102 contained only a narrow Lion style zone, the high-grade tenor of the copper-dominant mineralization (1.00 meter at 6.37% CuEqRec) is similar to the high-grade Lion Zone, suggesting potential for high-grade mineralization within the Tiger Zone.
It’s worth noting that “CuEqRec” refers to Copper Equivalent Recoverable, a calculation based on current metal prices and an assumed recovery grade of 80% for all commodities. This metric allows for comparison between different intersections containing varying amounts of the different metals.
Significance and Future Plans
The Tiger Zone, while still in early stages of exploration, is becoming increasingly important within Power Metallic’s portfolio. CEO Terry Lynch has stated: “As a stand-alone prospect, Tiger is becoming increasingly compelling. It’s not yet at Lion’s level, but recent results show clear promise.”
The winter 2025 drilling campaign has concluded for the season, with drilling expected to restart in late May after the annual spring breakup period. During this shutdown, Power Metallic plans to double the core facility at Nisk to accommodate up to six drills, indicating a significant ramp-up in exploration activities.
The company has also conducted borehole electromagnetic surveys on the recently completed holes, which have defined multiple off-hole EM anomalies. These anomalies will help direct future exploration in the Tiger area when drilling resumes. Additionally, results from two additional exploration holes in the Tiger area are expected in the coming weeks.
The shutdown coincides with respecting the annual goose hunt held every spring by the indigenous Cree nations, highlighting Power Metallic’s commitment to maintaining positive relationships with local indigenous communities. The company has participated with 15 other mining and exploration companies in providing financial contributions for the Reconstruction Initiative Forest Fires Fund 2023, demonstrating corporate social responsibility.
Conclusion
The Tiger Zone represents an exciting new discovery within Power Metallic’s NISK project. While still in the early stages of exploration, the zone has already demonstrated characteristics that make it a compelling prospect: shallow mineralization, polymetallic composition, high-grade intersections, and significant exploration potential.
As Power Metallic continues to explore and define the Tiger Zone, investors and industry observers will be watching closely to see if this discovery develops into a significant deposit that could enhance the overall value of the NISK project. With a major drilling campaign planned for the summer of 2025 utilizing six drill rigs, the coming months should provide substantial new information about the Tiger Zone’s potential.
The discovery and ongoing exploration of the Tiger Zone exemplify the methodical, science-based approach to mineral exploration that can lead to significant discoveries even in areas adjacent to known mineralization. For Power Metallic, the Tiger Zone may prove to be an important component of their vision to develop the NISK project into Canada’s next polymetallic mine.
Disclaimer
Effective Date: January 1, 2025
Ending Date: July 1, 2025
General Disclaimer: Lussosnews.com (WE) provides information solely for educational and informational purposes. WE are not registered investment advisors, broker-dealers, or financial professionals and do not offer personalized financial, investment, legal, or tax advice.
Not an Offer or Recommendation: The content provided does not constitute an offer, solicitation, or recommendation to buy, sell, or hold any securities. Readers should conduct independent research and consult a licensed professional before making decisions.
Forward-Looking Statements: Content may include forward-looking statements subject to risks and uncertainties. Actual results may differ. Readers should evaluate risks and not rely solely on these statements.
Risk Acknowledgment: Investing involves risks, including the potential for total loss. Do not invest funds you cannot afford to lose.
Compensation Disclosure: WE have been compensated 20,000 USD by a third party for coverage of Power Nickel ($PNPN, $PNPNF). This payment creates a material conflict of interest.
Liability Disclaimer: WE are not liable for any financial losses or damages resulting from the use of this content. By accessing our content, you agree to these terms.
SEC Compliance: WE comply with SEC regulations requiring transparency for compensated coverage. Readers are encouraged to verify all information independently.
Professional Advice: Always seek guidance from a qualified investment advisor, tax professional, or attorney before making decisions.
User Agreement: By using this site, you accept these terms. If you do not agree, please exit lussosnews.com immediately.
Stock Market
Hemostemix Revolutionizes Stem Cell Therapy Access with “Boots on the Ground” Strategy in Florida
Hemostemix Inc., a clinical-stage biotechnology company, is making headlines today with a bold new initiative aimed at expanding access to its autologous stem cell therapy, VesCell™ (ACP-01), across Florida under the state’s compassionate-use framework.

What’s New Today?
“Boots on the ground” initiative launched in Florida
Hemostemix has officially rolled out a face-to-face sales and outreach program in Miami, Naples, and Tampa. Spearheaded by CEO Thomas Smeenk and CCO Croom Lawrence, the team is engaging directly with podiatrists, cardiologists, vascular surgeons, and former Phase II trial investigators to build awareness and facilitate adoption of VesCell™ in clinics statewide.
Why It Matters
1. Regulatory Pathway Utilization
Florida’s SB 1768 right-to-try law allows Hemostemix to offer VesCell™ to patients with life-threatening or severely debilitating conditions who have exhausted standard-of-care options. This innovative approach enables patients to access cutting-edge treatments while Hemostemix gathers real-world evidence to support future FDA submissions.
2. Substantive Clinical Evidence
By August 2025, Hemostemix has treated 498 patients, completed seven clinical studies involving 318 subjects, and published findings across 11 peer-reviewed journals—all reinforcing VesCell™’s safety and efficacy in treating conditions like CLTI, angina, and various cardiomyopathies.
Clinical highlights include dramatic ulcer healing (from 1.46 cm² down to 0.48 mm² in three months, p = 0.01), improved cardiac function, and enhanced patient comfort and mobility.
3. Building Clinical Partnerships
Hemostemix’s engagement model emphasizes relationship-building: they’re not just promoting a treatment—they’re collaborating with clinicians who are familiar with ACP-01 from the trials. The aim is to foster trust, streamline adoption, and ensure rigorous data collection for later regulatory interaction.
Broader Context: Strategy Meets Execution
- Funding and Growth
Hemostemix has secured multiple rounds of financing, including a recent private placement, giving the company resources to drive commercialization in Florida and prepare for eventual FDA interaction. - Dual Purpose Rollout
The Florida initiative both generates revenue through compassionate-use treatments and builds a robust evidence base for regulators—reinforcing Hemostemix’s long-term strategy.
Suggested Headlines to Raise Awareness
- Hemostemix Brings Stem Cell Therapy to Florida: “Boots on the Ground” Initiative Takes VesCell™ Directly to Clinics
- Autologous Stem Cell Access in Action: Hemostemix Engages Florida Clinicians to Transform Care for No-Option Patients
- From Trials to Treatment: Hemostemix’s On-the-Ground Strategy in Florida Sets Stage for Broader Approval
Why This Announcement Matters — In Short
- Patients: Offers new hope to individuals with severe, otherwise untreatable conditions.
- Clinicians: Provides direct access to a promising therapy and support for implementation.
- Investors: Demonstrates tactical commercialization with regulatory foresight and clinical validation.
- Industry: Signals a novel model for balancing compassionate use with evidence generation in biomedicine.
Sources
Disclosure: Lusso’s News, LLC(“EMV”) has been compensated by Hemostemix Inc. (“Hemostemix”) in the amount of $5,000 USD per month, commencing August 13, 2025, and continuing through September 31, 2025, with the possibility of extension until further notice. This compensation is for the creation and dissemination of content about Hemostemix, including but not limited to articles, website postings, social media updates, and other promotional materials.
The content produced by EMV is intended solely for informational purposes. It does not constitute an offer to sell, a solicitation to buy, or a recommendation regarding any security, investment product, or trading strategy. EMV is not a registered investment adviser or broker-dealer, and nothing in this content should be construed as personalized investment advice.
Investing in securities involves risks, including the potential loss of principal. Readers should conduct their own independent research, perform due diligence, and consult with a licensed financial adviser, attorney, or tax professional before making any investment decisions.
EMV’s compensation from Hemostemix presents a conflict of interest as EMV has a financial incentive to promote Hemostemix. As a result, the content may be biased and should not be relied upon as independent or impartial.
By accessing this content or the associated website, you acknowledge and agree to the terms of this disclaimer.
Stock Market
Snow Lake Energy (NASDAQ: LITM) Uses X to Spotlight Its Uranium Push
Snow Lake Resources Ltd., operating as Snow Lake Energy (NASDAQ: LITM), is stepping up its investor engagement with a new video series on X, showcasing its uranium exploration projects and expanding role in the global clean energy transition.
The Canadian-based critical minerals explorer is using social media to pull back the curtain on its operations, giving investors an inside look at how it’s aligning with U.S. energy security priorities and tapping into surging demand for nuclear power to fuel AI-driven infrastructure.
A Strategic Pivot Toward Uranium
Snow Lake Energy has undergone a major pivot, shifting focus from lithium toward uranium — a move driven by tightening global energy markets and nuclear’s rising profile as a clean, base-load power source.
- Pine Ridge Uranium Project (Wyoming): A 50/50 joint venture with Global Uranium & Enrichment Limited (GUE), strategically located in the Powder River Basin near Cameco’s Smith Ranch Mill, which processes up to 5.5 million pounds of U3O8 annually. Pine Ridge is advancing as an in-situ recovery (ISR) project with an aggressive 125,000-foot drill program set for 2025.
- Engo Valley Project (Namibia): Early results are promising, and Phase 2 drilling (7,500 meters) is underway to build out a stronger resource model.
This uranium focus comes as the U.S. government accelerates domestic nuclear investment through four Nuclear Executive Orders signed in May 2025, aimed at rapidly expanding nuclear deployment to meet AI-related energy needs.
Investor Outreach Through Multimedia
The X video series is part of Snow Lake’s strategy to make complex exploration updates digestible and exciting for investors. The clips likely feature:
- On-site footage from drill programs
- Expert commentary from leadership
- Visual data highlighting resource potential
By turning technical progress into compelling stories, Snow Lake is aiming to build momentum with both institutional and retail investors. CEO Frank Wheatley has repeatedly emphasized the company’s commitment to transparency and engagement, with the video rollout complementing frequent press releases and appearances at investor conferences such as ThinkEquity 2024.
Notably, Snow Lake has also partnered with Exodys Energy to create a new nuclear reactor development company focused on small modular reactors (SMRs), further solidifying its positioning in the clean energy sector.
Market Momentum and Investor Sentiment
The timing is crucial. Uranium prices have surged amid geopolitical pressures and global decarbonization policies, sparking renewed investor interest. Snow Lake’s own shares spiked more than 70% in December 2024 following a $15 million public offering at $0.80 per share to fund exploration.
Still, analysts remain cautious. Current ratings lean “hold,” citing negative returns on assets (-7.4%) and equity (-14.5%), even as sentiment around uranium builds. Snow Lake’s video series may be designed to counterbalance these headwinds by emphasizing long-term potential and policy tailwinds, especially with the U.S. targeting a quadrupling of nuclear power by 2050.
Outlook: Riding the Clean Energy Wave
With a market cap near $30.5 million (May 2025) and shares trading at $3.94, Snow Lake remains a speculative but ambitious small-cap. Its success depends on proving out Pine Ridge and Engo Valley while keeping investors engaged with visible progress.
By leaning on multimedia storytelling, Snow Lake is turning its corporate updates into a broader clean-energy narrative — one that investors tracking nuclear, AI power demand, and critical minerals will find increasingly hard to ignore.
As one X user recently put it, “Momentum is exploding for assets tied to the energy transition.” Snow Lake is clearly betting it can ride that wave.
👉 For more details, visit www.snowlakeenergy.com or follow @SnowLakeEnergy on X for the latest videos and corporate news.
Disclaimer
Lusso’s News, LLC (“we,” “our,” or “the Company”) has been compensated fifteen thousand U.S. dollars (USD $15,000) by a third party for investor awareness and media coverage related to Snow Lake Resources Ltd. (NASDAQ: LITM). This compensation is for a six-month period beginning June 2025 and ending December 2025.
The content provided by Lusso’s News, LLC, including but not limited to articles, videos, social media posts, and other media, is intended for informational and educational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. We are not registered as a broker-dealer, investment advisor, or in any other capacity with the U.S. Securities and Exchange Commission (SEC) or any state securities authority.
This material may contain forward-looking statements, including projections, forecasts, estimates, and other information that is predictive in nature. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the control of Snow Lake Resources Ltd. or Lusso’s News, LLC, that could cause actual results to differ materially from those anticipated. Readers should not place undue reliance on such statements.
Investing in securities, particularly micro-cap and small-cap stocks, involves substantial risk, including the potential for total loss of principal. Always conduct your own independent research and consult with a licensed financial advisor before making any investment decisions.
Lusso’s News, LLC assumes no responsibility or liability for any investment decisions made based on the information we provide. By viewing our content, you acknowledge and agree to these terms.
Stock Market
Hemostemix: Florida Law Opens Door for Stem Cell Therapy Expansion
On July 1, 2025, Florida enacted Senate Bill 1768, a landmark law allowing physicians to offer certain autologous stem cell therapies that are not yet FDA-approved, provided patients give informed consent and the procedures are conducted by licensed professionals.
This regulatory shift creates an immediate opportunity for Hemostemix Inc. (TSXV: HEM | OTCQB: HMTXF), a Canadian regenerative medicine company specializing in VesCell/ACP-01, a therapy designed to restore blood flow and promote healing in patients suffering from severe ischemia.
Why This Matters for Hemostemix
Hemostemix has already treated over 498 patients with ACP-01, showing trial results that include smaller ulcer sizes, improved circulation, and reduced amputation rates. With Florida’s new legal framework, the company can now commercialize VesCell in the Sunshine State before FDA approval—potentially accelerating both adoption and revenue. First treatments in Florida are targeted for late 2025, and Hemostemix projects $22.5 million in sales for 2026.
Learning from Other Biotech Breakouts
The biotech sector has a history of companies making exponential gains when innovation meets the right market conditions:
- Exact Sciences rose from ~$2 in 2013 to over $130 at its peak on the success of its Cologuard cancer test.
- Moderna was a relatively unknown small-cap before its mRNA platform propelled its COVID-19 vaccine to global use, driving shares from around $18 to nearly $500.
- Vertex Pharmaceuticals climbed more than 1,000% over a decade by pioneering treatments for cystic fibrosis.
- Regeneron surged over 600% on the blockbuster performance of its eye drug Eylea.
- Novavax went from under $5 to over $300 during the race to produce a COVID-19 vaccine.
Each of these cases involved a scientific breakthrough meeting favorable timing—whether regulatory changes, urgent public health needs, or key clinical results.
The Road Ahead
It’s important to note that VesCell remains investigational, and investment in early-stage biotech carries significant risk. Florida’s new law does not imply FDA approval; rather, it creates a pathway for patients and physicians to access therapies under specific conditions.
For Hemostemix, this legal shift may represent a pivotal moment—much like other inflection points that helped propel biotech companies from obscurity to the forefront of their fields. Whether the company follows that trajectory will depend on clinical performance, market uptake, and investor confidence in the years ahead.
Disclosure: Lusso’s News, LLC(“EMV”) has been compensated by Hemostemix Inc. (“Hemostemix”) in the amount of $5,000 USD per month, commencing August 13, 2025, and continuing through September 31, 2025, with the possibility of extension until further notice. This compensation is for the creation and dissemination of content about Hemostemix, including but not limited to articles, website postings, social media updates, and other promotional materials.
The content produced by EMV is intended solely for informational purposes. It does not constitute an offer to sell, a solicitation to buy, or a recommendation regarding any security, investment product, or trading strategy. EMV is not a registered investment adviser or broker-dealer, and nothing in this content should be construed as personalized investment advice.
Investing in securities involves risks, including the potential loss of principal. Readers should conduct their own independent research, perform due diligence, and consult with a licensed financial adviser, attorney, or tax professional before making any investment decisions.
EMV’s compensation from Hemostemix presents a conflict of interest as EMV has a financial incentive to promote Hemostemix. As a result, the content may be biased and should not be relied upon as independent or impartial.
By accessing this content or the associated website, you acknowledge and agree to the terms of this disclaimer.
-
Stock Market11 months agoQuantum BioPharma: Advancing Biotech Innovation Amid Market Manipulation Allegations
-
Stock Market11 months agoPower Metallic and Terry Lynch: Pioneering Canada’s Next Major Polymetallic Mine
-
Stock Market11 months agoSidney Resources: Pioneering Sustainable Mining with Strategic Growth and Environmental Innovation
-
Stock Market9 months agoTop 6 High-Growth Stocks to Watch This Week
-
Stock Market10 months agoWall Street Veteran Breaks Down Charts on MSTR and UNH
-
Stock Market8 months agoThe New Gold Rush: Why Investors Are Falling in Love With Minerals — And The One Nasdaq Stock That Stands Out
-
Stock Market9 months agoShort Gold, Long 10-Year Treasury Notes: A Contrarian Macro Strategy
-
Stock Market8 months agoIs This The TOP Drone Stock To Watch Today?
